Veru Inc. (VERU): Depreciation & Amortization
$152.1K
Year ended 2025-09-30
$113.2K
Trailing 12 months to 2026-06-30
-11.1%
10-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-09-30 | $152.1K | -43.3% | 2025-12-17, From 2024-10-01 |
| 2024-09-30 | $268.2K | -0.6% | 2025-12-17, From 2023-10-01 |
| 2023-09-30 | $269.9K | n/a | 2024-12-16, From 2022-10-01 |
| No annual figure between 2018-09-30 and 2023-09-30. | |||
| 2018-09-30 | $176.8K | -47.1% | 2018-12-13, From 2017-10-01 |
| 2017-09-30 | $334.0K | -21.0% | 2018-12-13, From 2016-10-01 |
| 2016-09-30 | $422.9K | -14.4% | 2018-01-02, From 2015-10-01 |
| 2015-09-30 | $494.3K | -16.1% | 2018-01-02, From 2014-10-01 |
| 2014-09-30 | $589.3K | +5.9% | 2016-12-12, From 2013-10-01 |
| 2013-09-30 | $556.3K | +20.6% | 2015-12-02, From 2012-10-01 |
| 2012-09-30 | $461.4K | -0.7% | 2014-12-02, From 2011-10-01 |
| 2011-09-30 | $464.9K | -0.4% | 2013-12-03, From 2010-10-01 |
| 2010-09-30 | $466.5K | +73.8% | 2011-12-02, From 2009-10-01 |
| 2009-09-30 | $268.4K | n/a | 2011-12-02, From 2008-10-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Veru Inc. (VERU) | 2025-09-30 | $152.1K | -43.3% |
| Sol-Gel Technologies Ltd. (SLGL) | 2025-12-31 | $109.0K | -53.2% |
| Talphera, Inc. (TLPH) | 2024-12-31 | $0 | -100.0% |
| Sunshine Biopharma Inc. (SBFM) | 2025-12-31 | $332.1K | +48.6% |
| Yarrow Bioscience, Inc. (YARW) | 2025-12-31 | $23.0K | +475.0% |
| China Pharma Holdings, Inc. (CPHI) | 2025-12-31 | $1.50M | -42.6% |
| Neuphoria Therapeutics Inc. (NEUP) | 2026-06-30 | $663.0K | 0.0% |
| Biofrontera Inc. (BFRI) | 2025-12-31 | $138.0K | -67.2% |
| Skye Bioscience, Inc. (SKYE) | 2025-12-31 | $723.4K | +142.2% |
Compare VERU, SLGL, TLPH, SBFM side by side · Screen every company in Pharmaceutical Preparations ↗